Simultaneous activation of several key receptor tyrosine kinase (RTKs) induces sustained and profound activation of downstream cascades, including PI3K-Akt-mTOR and Erk-MAPK, promoting glioma cell progression [11, 23, 24]. The gene discussed is NTRK1; the disease is glioma.